Januvia 100 MG tablet 1000S
Ended Awarded
- Contract number
- SPE2DB25FXALF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,023
Award facts
- Contract value 100% obligated
- $26,023.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,023.49 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (1,000 count) on September 24, 2025. This is a firm fixed-price contract with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio demonstrates extensive capability across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This award for Januvia, a diabetes treatment medication, exemplifies the company's ongoing role in fulfilling federal medical supply needs through the DLA's Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FXALF?
SPE2DB25FXALF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FXALF worth?
The government has obligated $26,023 on SPE2DB25FXALF.
Is contract SPE2DB25FXALF an order under another contract?
Yes. SPE2DB25FXALF is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXALF competed?
The extent of competition for SPE2DB25FXALF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award